Ruxolitinib, 100mg

Ruxolitinib, 100mg

Isotretinoin (13-cis retinoic acid), 50mg

Isotretinoin (13-cis retinoic acid), 50mg

Ruxolitinib, 1g

19.192,32 RON
SKU
SKM_S1378_1g

Ruxolitinib is the first potent, selective, JAK1/2inhibitor to enter the clinic with IC50of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3. Ruxolitinib kills tumor cells through toxic mitophagy. Ruxolitinib induces autophagyand enhances apoptosis.

Mai multe informatii
Price 16.128,00 RON (preturile sunt fara TVA)
Description

Ruxolitinib is the first potent, selective, JAK1/2inhibitor to enter the clinic with IC50of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3. Ruxolitinib kills tumor cells through toxic mitophagy. Ruxolitinib induces autophagyand enhances apoptosis.